# A Study of PYX-201 in Advanced Solid Tumors

> **NCT05720117** · PHASE1 · RECRUITING · sponsor: **Pyxis Oncology, Inc** · enrollment: 330 (estimated)

## Conditions studied

- Solid Tumor
- Advanced Solid Tumor

## Interventions

- **DRUG:** PYX-201

## Key facts

- **NCT ID:** NCT05720117
- **Lead sponsor:** Pyxis Oncology, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-14
- **Primary completion:** 2026-07
- **Final completion:** 2027-05
- **Target enrollment:** 330 (ESTIMATED)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05720117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05720117, "A Study of PYX-201 in Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05720117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*